Tang Capital Management’s BioNTech BNTX Stock Holding History

Tang Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.7M	Hold	470,000	–	–	1.99%	16
2026 Q1	$41.8M	Hold	470,000	–	–	2.12%	18
2025 Q4	$44.7M	Buy	470,000 +200,000	+74%	+$20.1M	2.21%	16
2025 Q3	$26.6M	Hold	270,000	–	–	1.03%	29
2025 Q2	$28.7M	Hold	270,000	–	–	1.45%	20
2025 Q1	$24.6M	Hold	270,000	–	–	1.36%	18
2024 Q4	$30.8M	Hold	270,000	–	–	2.04%	12
2024 Q3	$32.1M	Buy	+270,000	New	+$24.8M	2.29%	10
2023 Q1	–	Sell	-30,000	Closed	-$4.51M	–	109
2022 Q4	$4.51M	Hold	30,000	–	–	0.65%	38
2022 Q3	$4.05M	Sell	30,000 -10,000	-25%	-$1.53M	0.5%	46
2022 Q2	$5.96M	Hold	40,000	–	–	0.91%	27
2022 Q1	$6.82M	Buy	+40,000	New	+$6.72M	1.36%	23

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Tang Capital Management's BNTX Position: Q2 2026 in Review

Tang Capital Management held its BioNTech (BNTX) position steady in Q2 2026 at 470,000 shares worth $43.7M. The position accounts for 1.99% of the portfolio, ranked #16.

Tang Capital Management first reported a position in BNTX in Q1 2022 and has held it in 12 quarters since. The position peaked at $44.7M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Tang Capital Management held 470,000 shares of BioNTech worth $43.7M as of Q2 2026.
Tang Capital Management left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 1.99% of Tang Capital Management's portfolio in Q2 2026, its #16 holding.
Tang Capital Management first reported a position in BioNTech in Q1 2022 and has held it in 12 quarters since.
Tang Capital Management's BioNTech position peaked at $44.7M in Q4 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.